You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Boehringer Ingelheim
McKesson
Baxter
Colorcon

Last Updated: February 22, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for D-glucose


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the drug development status for D-glucose?

D-glucose is an investigational drug.

There have been 31 clinical trials for D-glucose. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2009.

The most common disease conditions in clinical trials are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and Carcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and University of Maryland.

Recent Clinical Trials for D-glucose
TitleSponsorPhase
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung NodulesCanary FoundationPhase 2
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung NodulesStanford UniversityPhase 2
Fluorine F 18 Fluorthanatrace PET/CT in Treating Participants With Primary or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerNational Cancer Institute (NCI)Phase 1

See all D-glucose clinical trials

Clinical Trial Summary for D-glucose

Top disease conditions for D-glucose
Top clinical trial sponsors for D-glucose

See all D-glucose clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Merck
AstraZeneca
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.